([(2-Bromo-4-sulfamoyl-phenylcarbamoyl)-methyl]-{2-[(2-{[(2-bromo-4-sulfamoyl-phenylcarbamoyl)-methyl]-carboxymethyl-amino}-ethyl)-carboxymethyl-amino]-ethyl}-amino)-acetic acid

InChIKey	`UHLGJGLIMGHELQ-UHFFFAOYSA-N`
Compound Name	([(2-Bromo-4-sulfamoyl-phenylcarbamoyl)-methyl]-{2-[(2-{[(2-bromo-4-sulfamoyl-phenylcarbamoyl)-methyl]-carboxymethyl-amino}-ethyl)-carboxymethyl-amino]-ethyl}-amino)-acetic acid
Canonical SMILES	`NS(=O)(=O)c1ccc(NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)Nc2ccc(S(N)(=O)=O)cc2Br)CC(=O)O)CC(=O)O)c(Br)c1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	7.7
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P00918	CA2	Homo sapiens	Human	PF00194	8.0	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	8.0	pIC50	TTD_MultiTarget
P22748	CA4	Homo sapiens	Human	PF00194	7.7	Ki	ChEMBL;BindingDB
P00915	CA1	Homo sapiens	Human	PF00194	7.1	Ki	ChEMBL;BindingDB